Clinical Trials Browser

Phase 2 × cabazitaxel × Tumor-Agnostic × Clear all

NCT02035124 2016-02-11

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Phase 2 Withdrawn

Neoplasm Metastasis